| Literature DB >> 32049046 |
Jue Jiang1, Jingchao Wang1, Ming Yue2, Xiaolian Cai3, Tianci Wang4, Chao Wu4, Hexiu Su4, Yanwu Wang5, Meng Han6, Yingchi Zhang7, Xiaofan Zhu7, Peng Jiang8, Peng Li9, Yonghua Sun10, Wuhan Xiao3, Hui Feng10, Guoliang Qing1, Hudan Liu11.
Abstract
Deregulation of MYC plays an essential role in T cell acute lymphoblastic leukemia (T-ALL), yet the mechanisms underlying its deregulation remain elusive. Herein, we identify a molecular mechanism responsible for reciprocal activation between Aurora B kinase (AURKB) and MYC. AURKB directly phosphorylates MYC at serine 67, counteracting GSK3β-directed threonine 58 phosphorylation and subsequent FBXW7-mediated proteasomal degradation. Stabilized MYC, in concert with T cell acute lymphoblastic leukemia 1 (TAL1), directly activates AURKB transcription, constituting a positive feedforward loop that reinforces MYC-regulated oncogenic programs. Therefore, inhibitors of AURKB induce prominent MYC degradation concomitant with robust leukemia cell death. These findings reveal an AURKB-MYC regulatory circuit that underlies T cell leukemogenesis, and provide a rationale for therapeutic targeting of oncogenic MYC via AURKB inhibition.Entities:
Keywords: Aurora B kinase; FBXW7; MYC; T-ALL; patient-derived xenograft; phosphorylation; protein stability; zebrafish T-ALL model
Mesh:
Substances:
Year: 2020 PMID: 32049046 PMCID: PMC7321798 DOI: 10.1016/j.ccell.2020.01.001
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743